Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?14.06
 
WKN: A2PL3P / Symbol: ONCT / Name: Oncternal Therapeutics / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Oncternal Therapeutics Inc. Stock

Our community is currently low on Oncternal Therapeutics Inc. with 4 Buy predictions and 20 Sell predictions.
However, we have a potential of 4330.38% for Oncternal Therapeutics Inc. as the target price of 14 € is above the current price of 0.32 €.
For the coming years our community has positive and negative things to say abot the Oncternal Therapeutics Inc. stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.

Pros and Cons of Oncternal Therapeutics Inc. in the next few years

Pros
?
C******** o* t** e**********
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
W********* I********* f** t** n*** y****
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 26.281
Change
Ends at 15.04.25

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target lowered by analysts at HC Wainwright from $30.00 to $28.00. They now have a "buy" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 27.720
Change
Ends at 29.01.25

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) had its price target raised by analysts at HC Wainwright to $30.00. They now have a "buy" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Show more

Oncternal Therapeutics, Inc. (NASDAQ: ONCT) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for ONCT provided by MarketBeat
Show more